ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q2SCImago #10,719Hybrid

Clinical Pharmacology in Drug Development

Acronym:cpd
•
Abbreviation (ISO):Clin. Pharmacol. Drug Dev
•
Identifier (ISSN):2160-7648(Print)/2160-763X(Online)
•
Publisher:Wiley-Blackwell
Clarivate IF (2026)
1.7↓ -0.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Clinical Pharmacology in Drug Development

WoS Q3
01341.3820182.2320191.920202.4520212.152022220231.520241.820251.72026
Annual Impact Factor Metric
Current (2026):1.7
Scopus SJR & RankScopus Q2
0.553
#10,719

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
42

42 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate6.7%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
127articles/year
47.75% Gold OA•99.31% Original Research

Aims & Scope

Clinical Pharmacology in Drug Development is an international, peer-reviewed, online publication focused on publishing high-quality clinical pharmacology studies in drug development which are primarily (but not exclusively) performed in early development phases in healthy subjects.

Topics Covered (Recognized by AI)
Medicine99.6%Biology82.2%Internal medicine79.5%Pharmacology78.7%Bioinformatics72.4%Pharmacokinetics68.9%Pathology55.5%Endocrinology54.6%Chemistry53.6%Alternative medicine45%Bioavailability40.6%Biochemistry37.4%Placebo35%Adverse effect34.6%Genetics34.6%Plasma concentration30.8%Organic chemistry29.3%Cmax29.2%Psychology26.3%Psychiatry23.9%Crossover study23.6%Anesthesia22.7%Surgery21.8%Mathematics20.6%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

PHARMACOLOGY & PHARMACY

Q3
Rank267/356
IndexSCIE
JCISCIE2026

PHARMACOLOGY & PHARMACY

Q3
Rank239/356
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF1.7
Articles / Year108
Total Citations24
2025
IF1.8
Articles / Year153
Total Citations149
2024
IF1.5
Articles / Year154
Total Citations429
2023
IF2
Articles / Year151
Total Citations649
2022
IF2.151
Articles / Year174
Total Citations1,044

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #10,719Scopus Q2SCImago Profile
Scopus Coverage:2012-2026
Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q2
0.553

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
1.71

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,037 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations724
3-Year Documents422
Citable Documents410

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate45.4%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Pharmaceutical ScienceQ2
Pharmacology (medical)Q3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 6.7%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区PHARMACOLOGY & PHARMACY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Clinical Pharmacology in Drug Development (acronym: cpd, abbr: Clin. Pharmacol. Drug Dev, ISSN: 2160-7648) is a peer-reviewed international scholarly journal in the field of PHARMACOLOGY & PHARMACY, published by Wiley-Blackwell in United States. The periodical holds a Journal Impact Factor (JIF) of 1.70, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.553 (Q2), an H-index of 42.

The journal enforces rigorous peer evaluation with an annual output of approximately 127 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,037 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Wiley-Blackwell
Publication Language
English
Frequency
Periodic
Indexing & Databases
SCIEScopusPubMed
Editorial Address
111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 33eed44d-922c-435e-8e28-bee1122ea172
Database Updated: 2026-09-30